Literature DB >> 2289413

Myelin/oligodendrocyte glycoprotein expression during development in normal and myelin-deficient mice.

J M Matthieu1, P Amiguet.   

Abstract

The myelin/oligodendrocyte glycoprotein (MOG) is identified by monoclonal antibody 8-18C5. MOG is localized on the surface of myelin and oligodendrocyte processes. Recently, several studies have shown that MOG plays an important role as a target for antibody-induced demyelination. In the present study, we investigated MOG expression in the brains of normal and myelin-deficient (mld) mutant mice during development. By gel electrophoresis and immunoblotting, we observed the developmental pattern of two closely migrating bands, with apparent molecular masses of 26 and 28 kilodaltons. Their concentrations increased coordinately during the most active phase of myelin and myelin basic protein (MBP) synthesis. Between 20 and 25 days of age, the MOG developmental pattern superimposed that of MBP as well as myelin yields. In mld mutant mice, which are affected by a severe deficit of MBP synthesis, MOG was present at reduced levels (40% of controls at 60 days of age). At 85 days of age, mld mice exhibited increased concentrations of MBP, and myelin was better compacted. At this age, MOG concentrations increased and reached 70% of controls. These results suggest that MOG could play a role in the maintenance or completion of the myelin sheath. Its expression level may be modulated by the presence of compact myelin and/or MBP in the myelin sheath.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2289413     DOI: 10.1159/000111858

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  12 in total

1.  Identification of seven new human MHC class I region genes around the HLA-F locus.

Authors:  W Fan; W Cai; S Parimoo; D C Schwarz; G G Lennon; S M Weissman
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

Review 2.  Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination.

Authors:  H C von Büdingen; N Tanuma; P Villoslada; J C Ouallet; S L Hauser; C P Genain
Journal:  J Clin Immunol       Date:  2001-05       Impact factor: 8.317

Review 3.  Glycoproteins of myelin sheaths.

Authors:  R H Quarles
Journal:  J Mol Neurosci       Date:  1997-02       Impact factor: 3.444

4.  Developmental expression of MOSP in cultured oligodendrocytes.

Authors:  Q Q Mu; C Dyer
Journal:  Neurochem Res       Date:  1994-08       Impact factor: 3.996

5.  Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex.

Authors:  D Pham-Dinh; M G Mattei; J L Nussbaum; G Roussel; P Pontarotti; N Roeckel; I H Mather; K Artzt; K F Lindahl; A Dautigny
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

Review 6.  Novel oligodendrocyte transmembrane signaling systems. Investigations utilizing antibodies as ligands.

Authors:  C A Dyer
Journal:  Mol Neurobiol       Date:  1993       Impact factor: 5.590

7.  Biochemical and immunohistochemical studies with specific polyclonal antibodies directed against bovine myelin/oligodendrocyte glycoprotein.

Authors:  M C Birling; G Roussel; F Nussbaum; J L Nussbaum
Journal:  Neurochem Res       Date:  1993-08       Impact factor: 3.996

8.  Neuronal Circuit Activity during Neonatal Hypoxic-Ischemic Seizures in Mice.

Authors:  Jennifer Burnsed; Daria Skwarzyńska; Pravin K Wagley; Laura Isbell; Jaideep Kapur
Journal:  Ann Neurol       Date:  2019-10-18       Impact factor: 10.422

9.  Deletion of Jun proteins in adult oligodendrocytes does not perturb cell survival, or myelin maintenance in vivo.

Authors:  Bettina Schreiner; Barbara Ingold-Heppner; Debora Pehl; Giuseppe Locatelli; Helia Berrit-Schönthaler; Burkhard Becher
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

10.  Transcriptional Fingerprint of Hypomyelination in Zfp191null and Shiverer (Mbpshi) Mice.

Authors:  Joshua D Aaker; Benayahu Elbaz; Yuwen Wu; Timothy J Looney; Li Zhang; Bruce T Lahn; Brian Popko
Journal:  ASN Neuro       Date:  2016-09-28       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.